stock

Becton Dickinson & Co. (BDX)

Share

Stay up to date

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.

Financial Statements

Key Info

  • Industry: Surgical and Medical Instrument Manufacturing
  • Sector: Manufacturing
  • CEO Name: Thomas Polen

Key Statistics

  • Stock Price: $238.81
  • Dividend Yield: 1.5%
  • Market Capitalization: $69,072,829,250
  • Shares Outstanding: 290,405,000
  • Number of Employees: 77,000
  • Trailing 12-Month EPS: $4.94
  • Trailing 12-Month DPS: $3.66
  • Payout Ratio: 74.1%

Important Dates

  • Next Earnings Date: 2024-02-01
  • Next Ex-Dividend Date: 2023-12-07

Price Trends

  • Current Stock Price: $238.81
  • 52-week high: $285.17
  • 52-week low: $226.09
  • 200-day moving average: $254.39
  • 50-day moving average: $239.24

Performance

  • 1-Month Price Return: -2.5%
  • 3-Month Price Return: -5.1%
  • 6-Month Price Return: -14.5%
  • 1-Year Price Return: -4.1%
  • 2-Year Price Return: -1.9%
  • 5-Year Price Return: 7.6%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast